Sotera Health Co (SHC) - Total Liabilities
Based on the latest financial reports, Sotera Health Co (SHC) has total liabilities worth $2.64 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Sotera Health Co to see how much of total assets are deployed in long-term investments.
Sotera Health Co - Total Liabilities Trend (2018–2025)
This chart illustrates how Sotera Health Co's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Sotera Health Co asset portfolio.
Sotera Health Co Competitors by Total Liabilities
The table below lists competitors of Sotera Health Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Oilfield Services Ltd Class A
SHG:601808
|
China | CN¥36.18 Billion |
|
Cogent Biosciences Inc
NASDAQ:COGT
|
USA | $301.24 Million |
|
Technip Energies BV
PA:TE
|
France | €8.44 Billion |
|
Vishal Mega Mart Ord Shs
NSE:VMM
|
India | Rs40.36 Billion |
|
AB Sagax (publ)
ST:SAGA-B
|
Sweden | Skr49.48 Billion |
|
LB Group Co Ltd
SHE:002601
|
China | CN¥36.55 Billion |
|
Brookfield Business Corp
NYSE:BBUC
|
USA | $63.38 Billion |
|
Crispr Therapeutics AG
NASDAQ:CRSP
|
USA | $911.26 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Sotera Health Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Sotera Health Co (SHC) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sotera Health Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sotera Health Co (2018–2025)
The table below shows the annual total liabilities of Sotera Health Co from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $2.66 Billion | -0.36% |
| 2024-12-31 | $2.67 Billion | -0.74% |
| 2023-12-31 | $2.69 Billion | -2.92% |
| 2022-12-31 | $2.77 Billion | +25.60% |
| 2021-12-31 | $2.20 Billion | -4.48% |
| 2020-12-31 | $2.31 Billion | -28.40% |
| 2019-12-31 | $3.22 Billion | +20.98% |
| 2018-12-31 | $2.66 Billion | -- |
About Sotera Health Co
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide process… Read more